NetworkNewsBreaks – PreveCeutical Medical Inc. (
Post# of 77
Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) late Wednesday announced its entry into a letter of intent with Penta 5 Packaging Inc. and Penta 5 USA, LLC (together the “Penta 5 Group”) through which PreveCeutical intends to acquire the Penta 5 Group and its assets, including over 120 market-ready products and a 150,000-square-foot, state-of-the-art packaging facility. “The Transaction will significantly benefit PreveCeutical and its shareholders,” Stephen Van Deventer, chairman, CEO and president of PreveCeutical, stated in the news release. “The Penta 5 Group, led by R. Charles Murray, has recorded over 20 years of success in the wellness and packaging industries. Mr. Murray’s extensive industry experience and large distribution network will open doors to create many cannabis-based health and wellness products and expand into new markets, including animal health care.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer